Koibuchi, Nobutaka
Kumamoto University
3 papers on CoChat
Most cited papers
- Verified
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Lin, B., Koibuchi, N., Hasegawa, Y., Sueta, D., Toyama, K., Uekawa, K., Ma, M., Nakagawa, T., Kusaka, H., & Kim-Mitsuyama, S. (2014) · Cardiovascular Diabetology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 423
- Verified
Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion
Dong, Y.-F., Kataoka, K., Toyama, K., Sueta, D., Koibuchi, N., Yamamoto, E., Yata, K., Tomimoto, H., Ogawa, H., & Kim-Mitsuyama, S. (2011) · Hypertension
Neurological Disease Mechanisms and TreatmentsRenin-Angiotensin System Studies
Cited by 109
- Verified
Local production of activated factor X in atherosclerotic plaque induced vascular smooth muscle cell senescence
Sanada, F., Muratsu, J., Otsu, R., Shimizu, H., Koibuchi, N., Uchida, K., Taniyama, Y., Yoshimura, S., Rakugi, H., & Morishita, R. (2017) · Scientific Reports
Blood Coagulation and Thrombosis MechanismsAtherosclerosis and Cardiovascular Diseases
Cited by 41
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free